Trial reportZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2019
[Combined anluohuaxianwan and entecavir treatment significantly improve the improvement rate of liver fibrosis in patients with chronic hepatitis B virus infection].
Open access · greenAbstract readRandomized Controlled Trial
In one paragraph
Trial report in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.
- Comparison on different traditional Chinese medicine therapies for chronic hepatitis B liver fibrosis.Frontiers in pharmacology · 2022Pooled it
- Integrated evidence chain-based effectiveness evaluation of traditional Chinese medicines (Eff-iEC): A demonstration study.Acta pharmaceutica Sinica. B · 2025Article
- Inflammation-fibrosis interplay in inflammatory bowel disease: mechanisms, progression, and therapeutic strategies.Frontiers in pharmacology · 2025Review
- Mechanism-guided drug development and treatment for liver fibrosis: a clinical perspective.Frontiers in pharmacology · 2025Review
- Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022).Journal of clinical and translational hepatology · 2023Article
- An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir.Journal of clinical and translational hepatology · 2023Article
- Treatment of Liver Fibrosis after Hepatitis B with TCM Combined with NAs Evaluated by Noninvasive Diagnostic Methods: A Retrospective Study.Evidence-based complementary and alternative medicine : eCAM · 2023Article
- [Guidelines for the prevention and treatment of chronic hepatitis B (version 2022)].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2022Article
- Guidelines for Prevention and Treatment of Chronic Hepatitis B.Journal of clinical and translational hepatology · 2021Article
- [Consensus on secondary prevention of primary liver cancer (2021 version)].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021Article
- [A comparative study of 3.0T (1)H-MRS for varying degrees of liver fibrosis in cynomolgus monkeys].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2020Article
- Long-Term Traditional Chinese Medicine Combined with NA Antiviral Therapy on Cirrhosis Incidence in Chronic Hepatitis B Patients in the Real-World Setting: A Retrospective Study.Evidence-based complementary and alternative medicine : eCAM · 2020Article
- [The guidelines of prevention and treatment for chronic hepatitis B (2019 version)].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2019Article
- [Consensus on the diagnosis and therapy of hepatic fibrosis in].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors at 6 institutions in 1 country.
L MiaoDepartment of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing 100034, China; Department of Hepatology, the Third Hospital of Qinhuangdao, Qinhuangdao 066000, China.
W N YangDepartment of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing 100034, China.
X Q DongDepartment of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing 100034, China.
Z Q ZhangDepartment of Hepatology, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
S B XieDepartment of Infectious Disease, the Third Affiliated Hospital Sun Yat Sen University, Guangzhou 510630, China.
D Z ZhangDepartment of Infectious Diseases, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China; the Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou 310058, China.
X Q ZhangDepartment of Infectious Diseases, the First Hospital Affiliated to Army Medical University, Chongqing 400038, China.
J ChengBeijing Ditan Hospital, Capital Medical University, Beijing 100000, China.
G ZhangDepartment of Gastroenterology, the People's Hospital of Guangxizhuang Autonomous Region, Nanning 530021, China.
W F ZhaoDepartment of Infectious Diseases, Xinxiang Medical University Third Hospital, Xinxiang 453000, China.
Q XieDepartment of Infectious Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
Y X LiuDepartment of Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen 518112, China.
A L MaDepartment of Infectious Diseases, China-Japan Friendship Hospital, Beijing 100029, China.
J LiDepartment of Infectious Diseases, the First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China.
J ShangDepartment of Infectious Diseases, the People's Hospital of Henan Province, Zhengzhou 450003, China.
L BaiInfectious Disease Department of West China Hospital, Sichuan University, Chengdu 610041, China.
L H CaoDepartment of Hepatology, the Third Hospital of Qinhuangdao, Qinhuangdao 066000, China.
Z Q ZouYantai Infectious Diseases Hospital, Yantai 264000, China.
J B Lithe First Affiliated Hospital of Anhui Medical University, Hehui 230022, China.
F D LyuBeijing Youan Hospital, Capital Medical University, Beijing 100000, China.
H LiuBeijing Youan Hospital, Capital Medical University, Beijing 100000, China.
Z J Wangthe 305 Hospital of PLA, Beijing 100300, China.
M X Zhangthe 6th People's Hospital of Shenyang, Shenyang 110006, China.
L M Chenthe 5th Medical Center of PLA General Hospital, Beijing 100039, China.
W F LiangFirst Affiliated Hospital of Zhejiang University, Hangzhou 310058, China.
H GaoDepartment of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing 100034, China.
H ZhuangDepartment of Microbiology and Center of Infectious Diseases, Peking University Health Science Center, Beijing 100191, China.
H ZhaoDepartment of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing 100034, China.
G Q WangDepartment of Infectious Disease, Center for Liver Disease, Peking University First Hospital, Beijing 100034, China; Department of Infectious Diseases, Peking University International Hospital, Beijing 102206, China; the Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou 310058, China.
Peking University · CNChina-Japan Friendship Hospital · CNPeking University First Hospital · CNRuijin Hospital · CNShanghai Public Health Clinical Center · CNShenzhen Third People’s Hospital · CN
Funding
China Mega-Project for Infectious Diseases 2017ZX10203202, 2013ZX10002005China Mega-Project for Innovative Drugs 2016ZX09101065
Abstract
PubMed holds no abstract for this paper.
Indexed as
Antiviral AgentsDrugs, Chinese HerbalDrug Therapy, CombinationGuanineHepatitis B, ChronicHepatitis B virusHumansLiver CirrhosisTreatment OutcomeAntiviral AgentsDrugs, Chinese HerbalentecavirGuanineHepatitis B virusLiver fibrosisRegressionTreatment
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.